J&J halts COVID-19 vaccine trial due to unexplained illness.
14 oct 2020
Johnson &Johnson earlier this month joined the short list of vaccine markers in US. But now J&J has now temporarily stopped its study due to un explained illness in a trial participant .A spoke man from New Jersey Company confirmed an earlier report by health-care news provider STAT that the study was paused. A report say that the company has begun dosing around 60,000 volunteers. Which was stated the first big trial of an COVID -19 inoculation that may work after just one shot. The news of this temporarily stop came when Astra Zeneca temporarily stopped there tests of vaccine after a trial participant fell ill .The study has resumed in my countries but it remains halted in then US.